Long-Term Clinical Benefits of Pulsed Field Ablation in Paroxysmal Atrial Fibrillation: Subanalyses From the Multicenter inspIRE Trial
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F25%3A00010212" target="_blank" >RIV/00023884:_____/25:00010212 - isvavai.cz</a>
Result on the web
<a href="https://www.ahajournals.org/doi/10.1161/CIRCEP.124.013465" target="_blank" >https://www.ahajournals.org/doi/10.1161/CIRCEP.124.013465</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Long-Term Clinical Benefits of Pulsed Field Ablation in Paroxysmal Atrial Fibrillation: Subanalyses From the Multicenter inspIRE Trial
Original language description
Clinical effectiveness of catheter ablation in atrial fibrillation (AF) is typically characterized by 12-month freedom from atrial tachyarrhythmia recurrence. However, freedom from AF burden may serve as a more meaningful measure of patient-centered outcomes in assessing patient quality of life (QoL), antiarrhythmic drug (AAD) use, cardioversion rates, cardiovascular hospitalizations, and repeat ablation procedures.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů